$EDXC
Endexx Corp Stock $edxc

$edxc Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223033514 Filed on September 25, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023 Q1
Revenue		$118.6K	$2.834M
YoY Change		-71.64%	1012.87%
Cost Of Revenue		$114.5K	$2.440M
YoY Change		-36.28%	2990.41%
Gross Profit		$4.127K	$394.2K
YoY Change		-98.0%	124.32%
Gross Profit Margin		3.48%	13.91%
Selling, General & Admin		$751.5K	$807.4K
YoY Change		-9.51%	10.6%
% of Gross Profit		18208.63%	204.81%
Research & Development		$700.00	$1.490K
YoY Change		-74.43%	-91.02%
% of Gross Profit		16.96%	0.38%
Depreciation & Amortization		$2.170K	$2.360K
YoY Change		-67.32%	-53.73%
% of Gross Profit		52.58%	0.6%
Operating Expenses		$754.3K	$811.2K
YoY Change		-10.18%	7.92%
Operating Profit		-$750.2K	-$417.0K
YoY Change		18.52%	-27.6%
Interest Expense		$327.0K	-$1.109M
YoY Change		-27.38%	-52.03%
% of Operating Profit
Other Income/Expense, Net		-$1.271M	$0.00
YoY Change		-87.98%
Pretax Income		-$2.022M	-$1.526M
YoY Change		-81.97%	-45.1%
Income Tax
% Of Pretax Income
Net Earnings		-$1.839M	-$1.526M
YoY Change		-83.6%	-45.1%
Net Earnings / Revenue		-1550.61%	-53.83%
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share		$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	506.4M shares	505.3M shares	506.4M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$23.73K	$155.0K
YoY Change	239.97%	483.18%
Cash & Equivalents	$23.73K
Short-Term Investments
Other Short-Term Assets	$1.209M	$1.195M
YoY Change	1929.25%	4549.69%
Inventory	$586.9K	$645.0K
Prepaid Expenses	$1.209M
Receivables	$448.7K	$790.6K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.268M	$2.786M
YoY Change	84.94%	162.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$40.91K	$73.11K
YoY Change	28.74%	-83.36%
Goodwill	$9.807M
YoY Change
Intangibles
YoY Change
Long-Term Investments	$420.00	$420.00
YoY Change	0.0%	0.0%
Other Assets
YoY Change
Total Long-Term Assets	$9.895M	$9.897M
YoY Change	3215.53%	1301.6%
TOTAL ASSETS
Total Short-Term Assets	$2.268M	$2.786M
Total Long-Term Assets	$9.895M	$9.897M
Total Assets	$12.16M	$12.68M
YoY Change	697.68%	617.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.313M	$3.087M
YoY Change	71.75%	100.45%
Accrued Expenses	$73.88K	$1.878M
YoY Change	154.57%	-26.58%
Deferred Revenue	$100.0K
YoY Change	558.89%
Short-Term Debt	$930.0K	$1.000M
YoY Change
Long-Term Debt Due	$10.73M	$6.348M
YoY Change	47.25%	-16.52%
Total Short-Term Liabilities	$25.33M	$20.36M
YoY Change	2.22%	34.53%
LONG-TERM LIABILITIES
Long-Term Debt	$760.6K	$4.294M
YoY Change	384.78%	1630.15%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$760.6K	$4.294M
YoY Change	384.78%	1630.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$25.33M	$20.36M
Total Long-Term Liabilities	$760.6K	$4.294M
Total Liabilities	$26.09M	$23.84M
YoY Change	4.62%	54.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$48.26M
YoY Change	-12.49%
Common Stock	$50.64K
YoY Change	-2.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$14.92M	-$11.16M
YoY Change
Total Liabilities & Shareholders Equity	$12.16M	$12.68M
YoY Change	697.68%	617.08%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$1.839M	-$1.526M
YoY Change	-83.6%	-45.1%
Depreciation, Depletion And Amortization	$2.170K	$2.360K
YoY Change	-67.32%	-53.73%
Cash From Operating Activities	-$266.5K	$503.7K
YoY Change	149.87%	-388.31%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change		-100.0%
Cash From Investing Activities	$0.00	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	135.2K	-355.3K
YoY Change	56.05%
NET CHANGE
Cash From Operating Activities	-266.5K	503.7K
Cash From Investing Activities	0.000	0.000
Cash From Financing Activities	135.2K	-355.3K
Net Change In Cash	-131.3K	148.4K
YoY Change	556.12%	-189.81%
FREE CASH FLOW
Cash From Operating Activities	-$266.5K	$503.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001109486
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2022Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	EDXC	Default Penalties DefaultPenalties		usd
	EDXC	Default Penalties DefaultPenalties		usd
CY2023Q2	EDXC	Gain On Settlement Of Liabilities GainOnSettlementOfLiabilities		usd
CY2022Q2	EDXC	Gain On Settlement Of Liabilities GainOnSettlementOfLiabilities		usd
	EDXC	Gain On Settlement Of Liabilities GainOnSettlementOfLiabilities		usd
CY2023Q2	EDXC	Gain On Disposition Of Assets GainOnDispositionOfAssets		usd
	EDXC	Gain On Disposition Of Assets GainOnDispositionOfAssets		usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q2	EDXC	Stock Issued During Period Value Correction Of Prior Issuance StockIssuedDuringPeriodValueCorrectionOfPriorIssuance		usd
	EDXC	Shares Issued For Financing Costs SharesIssuedForFinancingCosts		usd
	EDXC	Warrants Issued For Financing Costs WarrantsIssuedForFinancingCosts		usd
	EDXC	Gain From Settlement Of Liabilities GainFromSettlementOfLiabilities		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	EDXC	Financing Costs FinancingCosts		usd
	EDXC	Default Penalty DefaultPenalty		usd
	EDXC	Increase Decrease In Right Of Use Asset And Liability IncreaseDecreaseInRightOfUseAssetAndLiability		usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	EDXC	Settlement Of Derivative Liability SettlementOfDerivativeLiability		usd
	EDXC	Convertible Notes And Interest Converted To Common Stock ConvertibleNotesAndInterestConvertedToCommonStock		usd
	EDXC	Prepaid Expenses From Note Payable PrepaidExpensesFromNotePayable		usd
	EDXC	Accrued Interest Settled Through Note Payable AccruedInterestSettledThroughNotePayable		usd
	EDXC	Property And Equipment Net Sold For Settlement Of Convertible Note And Interest Payable PropertyAndEquipmentNetSoldForSettlementOfConvertibleNoteAndInterestPayable		usd
	EDXC	Convertible Notes And Interest Payable Settled Through Sale Of Property And Equipment ConvertibleNotesAndInterestPayableSettledThroughSaleOfPropertyAndEquipment		usd
CY2023Q2	EDXC	Accrued Officer Salaries Current AccruedOfficerSalariesCurrent		usd
CY2022Q3	EDXC	Accrued Officer Salaries Current AccruedOfficerSalariesCurrent		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-30233
	dei	Entity Registrant Name EntityRegistrantName	Endexx Corporation
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	30-0353162
	dei	Entity Address Address Line1 EntityAddressAddressLine1	38246 North Hazelwood Circle
	dei	Entity Address City Or Town EntityAddressCityOrTown	Cave Creek
	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85331
	dei	City Area Code CityAreaCode	(480)
	dei	Local Phone Number LocalPhoneNumber	595-6900
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	506357952	shares
CY2023Q2	us-gaap	Cash Cash	23727	usd
CY2022Q3	us-gaap	Cash Cash	656776	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	113257	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	621042	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	448734	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	570406	usd
CY2023Q2	us-gaap	Inventory Adjustments InventoryAdjustments	1165078	usd
CY2022Q3	us-gaap	Inventory Adjustments InventoryAdjustments	1071469	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	586933	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	777912	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1208617	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1367100	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	2268011	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	3372194	usd
CY2023Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	420	usd
CY2022Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	420	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	84144	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	77044	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40905	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	48005	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	30038	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	34160	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16250	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16250	usd
CY2023Q2	us-gaap	Goodwill Goodwill	9807361	usd
CY2022Q3	us-gaap	Goodwill Goodwill	9807361	usd
CY2023Q2	us-gaap	Assets Assets	12162985	usd
CY2022Q3	us-gaap	Assets Assets	13278390	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3313480	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2647533	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	100032	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	43366	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	73880	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	172711	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	1039350	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	237703	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	938268	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	915230	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	57345	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	4291	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	8671591	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	4623872	usd
CY2023Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2063301	usd
CY2022Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	799575	usd
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	930000	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	8160129	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	8908686	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	35656	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	35656	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	25325687	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	18384332	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	7259260	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	7925926	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	760623	usd
CY2022Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	4587718	usd
CY2023Q2	us-gaap	Liabilities Liabilities	26086310	usd
CY2022Q3	us-gaap	Liabilities Liabilities	22972050	usd
CY2023Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	4878049	shares
CY2023Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	4878049	shares
CY2022Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	4878049	shares
CY2022Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	4878049	shares
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	2000000	usd
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	2000000	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	506357952	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	506357952	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	501376264	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	501376264	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	50636	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	50138	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33290481	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32914424	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48262132	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44398312	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-14920833	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-11433568	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	-1002492	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	-260092	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12162985	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13278390	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	118599	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	418151	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3444686	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	947428	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	114472	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	211359	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2912501	usd
	us-gaap	Cost Of Revenue CostOfRevenue	548651	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	4127	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	206792	usd
	us-gaap	Gross Profit GrossProfit	532185	usd
	us-gaap	Gross Profit GrossProfit	398777	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2168	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6638	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7100	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16838	usd
CY2023Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	132409	usd
CY2022Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	94311	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	387265	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	444255	usd
CY2023Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	55408	usd
CY2022Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	161317	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	225477	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	479684	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	383752	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	405015	usd
	us-gaap	Professional Fees ProfessionalFees	1389265	usd
	us-gaap	Professional Fees ProfessionalFees	1442346	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	700	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2738	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5249	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21675	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	179897	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	169766	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	881402	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	626864	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	754334	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	839785	usd
	us-gaap	Operating Expenses OperatingExpenses	2895758	usd
	us-gaap	Operating Expenses OperatingExpenses	3031662	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-750207	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-632993	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2363573	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2632885	usd
CY2023Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-295985	usd
CY2022Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-9424041	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	614002	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-11044226	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	648341	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	543230	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1954560	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1093823	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	327009	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	450287	usd
	us-gaap	Interest Expense InterestExpense	902089	usd
	us-gaap	Interest Expense InterestExpense	928664	usd
CY2022Q2	EDXC	Default Penalties DefaultPenalties	584738	usd
	EDXC	Default Penalties DefaultPenalties	584738	usd
	EDXC	Gain On Settlement Of Liabilities GainOnSettlementOfLiabilities	222748	usd
CY2022Q2	EDXC	Gain On Disposition Of Assets GainOnDispositionOfAssets	423950	usd
	EDXC	Gain On Disposition Of Assets GainOnDispositionOfAssets	423950	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1271335	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10578346	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2242647	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13004753	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2021542	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-11211339	usd
	us-gaap	Profit Loss ProfitLoss	-4606220	usd
	us-gaap	Profit Loss ProfitLoss	-15637638	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-182531	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-742400	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1839011	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-11211339	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3863820	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15637638	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	505295364	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	504758044	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	504511926	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	500181299	shares
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9987141	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	300000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	135813	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	360906	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-1647205	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-10837627	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-2779094	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13616721	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	155800	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	294643	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	162332	usd
CY2022Q2	EDXC	Stock Issued During Period Value Shares Issued For Conversion Of Interest StockIssuedDuringPeriodValueSharesIssuedForConversionOfInterest	222000	usd
CY2022Q2	EDXC	Stock Issued During Period Value Shares Issued For Default Penalty StockIssuedDuringPeriodValueSharesIssuedForDefaultPenalty	584738	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-11211339	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-23408547	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11693660	usd
CY2022Q4	EDXC	Shares Issued For Settlement Of Accounts Payable SharesIssuedForSettlementOfAccountsPayable	103000	usd
CY2022Q4	EDXC	Shares Issued For Settlement Of Accrued Expenses SharesIssuedForSettlementOfAccruedExpenses	84000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-1058885	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-12565545	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	60533	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	55000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1525793	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13975805	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	74022	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2021542	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15923325	usd
	us-gaap	Profit Loss ProfitLoss	-4606220	usd
	us-gaap	Profit Loss ProfitLoss	-15637638	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	55000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	455800	usd
	EDXC	Shares Issued For Financing Costs SharesIssuedForFinancingCosts	430456	usd
	EDXC	Warrants Issued For Financing Costs WarrantsIssuedForFinancingCosts	523238	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7100	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16838	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1939560	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	105447	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	614002	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-11044226	usd
	EDXC	Gain From Settlement Of Liabilities GainFromSettlementOfLiabilities	222748	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	423950	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	57250	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	93609	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	59622	usd
	EDXC	Financing Costs FinancingCosts	34682	usd
	EDXC	Default Penalty DefaultPenalty	584738	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-64422	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	185009	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-97370	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	63278	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-158483	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-42088	usd
	EDXC	Increase Decrease In Right Of Use Asset And Liability IncreaseDecreaseInRightOfUseAssetAndLiability	-4122	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	768947	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	908789	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	56666	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-21523	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-14831	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-14448	usd
	EDXC	Increase Decrease In Accrued Interest IncreaseDecreaseInAccruedInterest	801647	usd
	EDXC	Increase Decrease In Accrued Interest IncreaseDecreaseInAccruedInterest	871053	usd
	EDXC	Increase Decrease In Payroll And Taxes Payable Primarily Related Party IncreaseDecreaseInPayrollAndTaxesPayablePrimarilyRelatedParty	23038	usd
	EDXC	Increase Decrease In Payroll And Taxes Payable Primarily Related Party IncreaseDecreaseInPayrollAndTaxesPayablePrimarilyRelatedParty	264334	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1107839	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1227283	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	9500	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9500	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	999853	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	537500	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	203623	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1000000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	992710	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	70000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	474790	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1203476	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-633049	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14307	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	656776	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20867	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23727	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6560	usd
	us-gaap	Interest Paid Net InterestPaidNet	100442	usd
	us-gaap	Interest Paid Net InterestPaidNet	57611	usd
	EDXC	Settlement Of Derivative Liability SettlementOfDerivativeLiability	134555	usd
	EDXC	Debt Discount At Origination DebtDiscountAtOrigination	62222	usd
	EDXC	Debt Discount At Origination DebtDiscountAtOrigination	213420	usd
	EDXC	Convertible Notes And Interest Converted To Common Stock ConvertibleNotesAndInterestConvertedToCommonStock	222000	usd
	EDXC	Prepaid Expenses From Note Payable PrepaidExpensesFromNotePayable	60000	usd
	EDXC	Accrued Interest Settled Through Note Payable AccruedInterestSettledThroughNotePayable	7107	usd
	EDXC	Property And Equipment Net Sold For Settlement Of Convertible Note And Interest Payable PropertyAndEquipmentNetSoldForSettlementOfConvertibleNoteAndInterestPayable	401050	usd
	EDXC	Convertible Notes And Interest Payable Settled Through Sale Of Property And Equipment ConvertibleNotesAndInterestPayableSettledThroughSaleOfPropertyAndEquipment	825000	usd
CY2023Q2	EDXC	Working Capital Deficit WorkingCapitalDeficit	-23057676	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48262132	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5144560	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2088304	usd
	us-gaap	Profit Loss ProfitLoss	-4606220	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1107839	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_ziXIYVfmd3xd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zDudBEdDPSGa">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial statement preparation requires that management make estimates and assumptions which affect the reporting of assets and liabilities and the related disclosure of contingent assets and liabilities in order to report these financial statements in conformity with GAAP. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1208617	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1367100	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3444686	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	947428	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	250625193	shares
CY2022	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weightedaverage Remaining Contractual Life Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedaverageRemainingContractualLifeExercisable	P4Y10M24D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	88918645	shares
CY2023Q2	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Execisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExecisableNumber	88918645	shares
CY2023Q2	us-gaap	Inventory Adjustments InventoryAdjustments	1165078	usd
CY2022Q3	us-gaap	Inventory Adjustments InventoryAdjustments	1071469	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	586933	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	777912	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	8160129	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	8908686	usd
CY2022Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	8908686	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	134555	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease	614002	usd
CY2023Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	8160129	usd
CY2021Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	1799354	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease	-11044226	usd
CY2022Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	12843580	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	7354059	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	4582366	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3400	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3500	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	387265	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	444255	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	250625193	shares
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	3600	usd
CY2023Q2	EDXC	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	8005807	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	242264	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	249043	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1341596	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1427017	usd
CY2023Q2	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	71965	usd
CY2022Q3	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	77135	usd
CY2023Q2	EDXC	Inventory Apparel InventoryApparel	96186	usd
CY2022Q3	EDXC	Inventory Apparel InventoryApparel	96186	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	19952732	usd
CY2023Q2	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weightedaverage Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedaverageExercisePrice	0.03
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	125049	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	125049	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	84144	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	77044	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40905	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	48005	usd
CY2022Q4	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.09	pure
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	886469	usd
CY2023Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.08	pure
CY2023Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	1000000	usd
CY2023Q2	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	500000	usd
CY2023Q2	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2023-07-11
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	17141807	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	7930217	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	17141807	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	7930217	usd
CY2022Q3	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weightedaverage Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedaverageExercisePrice	0.03
CY2022	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weightedaverage Remaining Contractual Life Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedaverageRemainingContractualLifeOutstanding	P4Y10M24D
CY2023Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	128105	usd
CY2022Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	128105	usd
CY2023Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	810163	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	787125	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	938268	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	915230	usd
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one vote per share
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	506357952	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	506357952	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	501376264	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	501376264	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	88918645	shares
CY2022Q3	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Execisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExecisableNumber	88918645	shares
CY2022Q3	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weightedaverage Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedaverageExercisePrice	0.03
CY2023Q2	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weightedaverage Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedaverageExercisePrice	0.03
	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weightedaverage Remaining Contractual Life Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedaverageRemainingContractualLifeOutstanding	P4Y2M12D
	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weightedaverage Remaining Contractual Life Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedaverageRemainingContractualLifeExercisable	P4Y2M12D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22500000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	22500000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.01
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.01
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y10M24D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y10M24D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22500000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	22500000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.01
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.01
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y2M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y2M12D
	us-gaap	Officers Compensation OfficersCompensation	22000	usd

Files In Submission

Name	View Source	Status
0001493152-23-033514-index-headers.html	Edgar Link	pending
0001493152-23-033514-index.html	Edgar Link	pending
0001493152-23-033514.txt	Edgar Link	pending
0001493152-23-033514-xbrl.zip	Edgar Link	pending
edxc-20230630.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
edxc-20230630_cal.xml	Edgar Link	unprocessable
edxc-20230630_def.xml	Edgar Link	unprocessable
edxc-20230630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
edxc-20230630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EDXC
Endexx Corp Stock $edxc

2023 Q3 Form 10-Q Financial Statement

#000149315223033514 Filed on September 25, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EDXC Endexx Corp Stock $edxc

2023 Q3 Form 10-Q Financial Statement

#000149315223033514 Filed on September 25, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EDXC
Endexx Corp Stock $edxc